{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:28:42Z","timestamp":1793305722626,"version":"4.5.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Comorbidities contribute to disease severity and mortality in patients with chronic obstructive pulmonary disease (COPD). Comorbidities have been studied individually and were mostly based on self-reports. The coexistence of objectively identified comorbidities and the role of low-grade systemic inflammation in the pathophysiology of COPD remain to be elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To cluster 13 clinically important objectively identified comorbidities, and to characterize the comorbidity clusters in terms of clinical outcomes and systemic inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 213 patients with COPD (FEV1, 51 \u00b1 17% predicted; men, 59%; age, 64 \u00b1 7 yr) were included prospectively. Comorbidities were based on well-known cut-offs identified in the peer-reviewed English literature. Systemic inflammatory biomarkers were determined in all patients. Self-organizing maps were used to generate comorbidity clusters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>A total of 97.7% of all patients had one or more comorbidities and 53.5% had four or more comorbidities. Five comorbidity clusters were identified: (1) less comorbidity, (2) cardiovascular, (3) cachectic, (4) metabolic, and (5) psychological. Comorbidity clusters differed in health status but were comparable with respect to disease severity. An increased inflammatory state was observed only for tumor necrosis factor (TNF) receptors in the metabolic cluster (geometric mean [lower and upper limit]; TNF-R1, 2,377 [1,850, 3,055] pg\/ml, confidence, 98.5%; TNF-R2, 4,080 [3,115, 5,344] pg\/ml, confidence, 98.8%) and only for IL-6 in the cardiovascular cluster (IL-6, 3.4 [1.8, 6.6] pg\/ml; confidence, 99.8%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Multimorbidity is common in patients with COPD, and different comorbidity clusters can be identified. Low-grade systemic inflammation is mostly comparable among comorbidity clusters. Increasing knowledge on the interactions between comorbidities increases the understanding of their development and contributes to strategies for prevention or improved treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201209-1665oc","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T03:10:28Z","timestamp":1360293028000},"page":"728-735","source":"Crossref","is-referenced-by-count":682,"title":["Clusters of Comorbidities Based on Validated Objective Measurements and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"187","author":[{"given":"Lowie E. G. W.","family":"Vanfleteren","sequence":"first","affiliation":[{"name":"Program Development Centre, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands"},{"name":"Department of Respiratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn A.","family":"Spruit","sequence":"additional","affiliation":[{"name":"Program Development Centre, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Groenen","sequence":"additional","affiliation":[{"name":"Program Development Centre, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetlana","family":"Gaffron","sequence":"additional","affiliation":[{"name":"Analytics, Viscovery Software GmbH, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa P. M.","family":"van Empel","sequence":"additional","affiliation":[{"name":"Program Development Centre, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands"},{"name":"Department of Cardiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet L. B.","family":"Bruijnzeel","sequence":"additional","affiliation":[{"name":"Clinical Respiratory and Inflammation, AstraZeneca, M\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica P. A.","family":"Rutten","sequence":"additional","affiliation":[{"name":"Program Development Centre, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Op \u2019t Roodt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel F. M.","family":"Wouters","sequence":"additional","affiliation":[{"name":"Program Development Centre, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands"},{"name":"Department of Respiratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits M. E.","family":"Franssen","sequence":"additional","affiliation":[{"name":"Program Development Centre, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands"},{"name":"Department of Respiratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,4,1]]},"reference":[{"key":"2026032100533759900_bib1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1465-9921-11-122","article-title":"Characterisation of COPD heterogeneity in the ECLIPSE cohort","volume":"11","author":"Agusti","year":"2010","journal-title":"Respir Res"},{"key":"2026032100533759900_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100533759900_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1378\/chest.10-2917","article-title":"The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD","volume":"140","author":"von Leupoldt","year":"2011","journal-title":"Chest"},{"key":"2026032100533759900_bib4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1183\/09031936.00012408","article-title":"Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD","volume":"32","author":"Mannino","year":"2008","journal-title":"Eur Respir J"},{"key":"2026032100533759900_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.201201-0034OC","article-title":"Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease","volume":"186","author":"Divo","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100533759900_bib6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/thx.2006.072348","article-title":"Ascertainment of cause-specific mortality in COPD: operations of the TORCH clinical endpoint committee","volume":"62","author":"McGarvey","year":"2007","journal-title":"Thorax"},{"key":"2026032100533759900_bib7","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1183\/09031936.97.10122794","article-title":"Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease","volume":"10","author":"Antonelli Incalzi","year":"1997","journal-title":"Eur Respir J"},{"key":"2026032100533759900_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/thx.2007.086371","article-title":"Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation","volume":"63","author":"Crisafulli","year":"2008","journal-title":"Thorax"},{"key":"2026032100533759900_bib9","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/thx.2009.128082","article-title":"Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care","volume":"65","author":"Feary","year":"2010","journal-title":"Thorax"},{"key":"2026032100533759900_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2466-12-26","article-title":"The prevalence of clinically-relevant comorbid conditions in patients with COPD: a cross-sectional study using data from NHANES 1999\u20132008","volume":"12","author":"Schnell","year":"2012","journal-title":"BMC Pulm Med"},{"key":"2026032100533759900_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/CLEP.S24818","article-title":"Characteristics of Dutch and Swiss primary care COPD patients: baseline data of the ice cold ERIC study","volume":"3","author":"Siebeling","year":"2011","journal-title":"Clin Epidemiol"},{"key":"2026032100533759900_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0895-4356(01)00346-8","article-title":"Ijzermans CJ, van der Zee JS, Bottema BJ, Schade E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40","volume":"54","author":"van Manen","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"2026032100533759900_bib13","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1378\/chest.128.4.2099","article-title":"Patterns of comorbidities in newly diagnosed COPD and asthma in primary care","volume":"128","author":"Soriano","year":"2005","journal-title":"Chest"},{"key":"2026032100533759900_bib14","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.amjcard.2011.07.027","article-title":"Frequency and relevance of ischemic electrocardiographic findings in patients with chronic obstructive pulmonary disease","volume":"108","author":"Vanfleteren","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026032100533759900_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"2026032100533759900_bib16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1164\/rccm.200701-067OC","article-title":"Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease","volume":"175","author":"Sabit","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100533759900_bib17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00128008","article-title":"Systemic manifestations and comorbidities of COPD","volume":"33","author":"Barnes","year":"2009","journal-title":"Eur Respir J"},{"key":"2026032100533759900_bib18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1164\/rccm.201206-1113OC","article-title":"Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease","volume":"186","author":"Thomsen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100533759900_bib19","doi-asserted-by":"crossref","first-page":"e37483","DOI":"10.1371\/journal.pone.0037483","article-title":"Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype","volume":"7","author":"Agusti","year":"2012","journal-title":"PLoS ONE"},{"key":"2026032100533759900_bib20","first-page":"A3674","article-title":"Objectified co-morbidities in patients with COPD: the CIROCO study","volume":"185","author":"Vanfleteren","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100533759900_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(08)60048-3","article-title":"Integration of pulmonary rehabilitation in COPD","volume":"371","author":"Spruit","year":"2008","journal-title":"Lancet"},{"key":"2026032100533759900_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2007.05.015","article-title":"Weighted multimorbidity indexes predicted mortality, health service use, and health-related quality of life in older women","volume":"61","author":"Tooth","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2026032100533759900_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1183\/09031936.00175109","article-title":"Clinical COPD phenotypes: a novel approach using principal component and cluster analyses","volume":"36","author":"Burgel","year":"2010","journal-title":"Eur Respir J"},{"key":"2026032100533759900_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/thx.2010.154484","article-title":"Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes","volume":"66","author":"Garcia-Aymerich","year":"2011","journal-title":"Thorax"},{"key":"2026032100533759900_bib25","doi-asserted-by":"crossref","first-page":"e51048","DOI":"10.1371\/journal.pone.0051048","article-title":"Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality","volume":"7","author":"Burgel","year":"2012","journal-title":"PLoS ONE"},{"key":"2026032100533759900_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1183\/09031936.00228511","article-title":"Clinical COPD phenotypes identified by cluster analysis: validation with mortality","volume":"40","author":"Burgel","year":"2012","journal-title":"Eur Respir J"},{"key":"2026032100533759900_bib27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1378\/chest.11-1456","article-title":"The relationship between pulmonary emphysema and kidney function in smokers","volume":"142","author":"Chandra","year":"2012","journal-title":"Chest"},{"key":"2026032100533759900_bib28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1164\/rccm.201004-0666OC","article-title":"Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort","volume":"183","author":"Bon","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100533759900_bib29","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1164\/rccm.200406-754OC","article-title":"Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease","volume":"170","author":"Bolton","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100533759900_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0002-9343(68)90234-9","article-title":"Chronic obstructive bronchopulmonary disease: II. Oxygen transport in two clinical types","volume":"44","author":"Filley","year":"1968","journal-title":"Am J Med"},{"key":"2026032100533759900_bib31","doi-asserted-by":"crossref","first-page":"e30556","DOI":"10.1371\/journal.pone.0030556","article-title":"Patterns of multimorbidity in the aged population: results from the KORA-age study","volume":"7","author":"Kirchberger","year":"2012","journal-title":"PLoS ONE"},{"key":"2026032100533759900_bib32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/HJR.0b013e32832e4206","article-title":"Anxiety and depression after acute myocardial infarction: an 18-month follow-up study with repeated measures and comparison with a reference population","volume":"16","author":"Hanssen","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2026032100533759900_bib33","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1164\/ajrccm.150.5.7952575","article-title":"Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease","volume":"150","author":"Di Francia","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100533759900_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1164\/rccm.200804-560OC","article-title":"Airflow limitation in smokers is associated with subclinical atherosclerosis","volume":"179","author":"Iwamoto","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100533759900_bib35","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1378\/chest.09-0393","article-title":"The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity","volume":"136","author":"Watz","year":"2009","journal-title":"Chest"},{"key":"2026032100533759900_bib36","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000056767.69054.B3","article-title":"Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease","volume":"107","author":"Sin","year":"2003","journal-title":"Circulation"},{"key":"2026032100533759900_bib37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/ajcn\/82.5.1059","article-title":"Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism","volume":"82","author":"Broekhuizen","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"2026032100533759900_bib38","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.rmed.2009.02.014","article-title":"Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic component","volume":"103","author":"Graat-Verboom","year":"2009","journal-title":"Respir Med"},{"key":"2026032100533759900_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/thx.2007.083493","article-title":"Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk","volume":"63","author":"Mills","year":"2008","journal-title":"Thorax"},{"key":"2026032100533759900_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1183\/09031936.00120107","article-title":"Relationship between depression and exacerbations in COPD","volume":"32","author":"Quint","year":"2008","journal-title":"Eur Respir J"},{"key":"2026032100533759900_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.physbeh.2007.10.010","article-title":"The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance","volume":"94","author":"Goossens","year":"2008","journal-title":"Physiol Behav"},{"key":"2026032100533759900_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/1479972307087205","article-title":"Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease","volume":"5","author":"Poulain","year":"2008","journal-title":"Chron Respir Dis"},{"key":"2026032100533759900_bib43","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.clnu.2009.05.005","article-title":"Highly elevated c-reactive protein levels in obese patients with COPD: a fat chance?","volume":"28","author":"Breyer","year":"2009","journal-title":"Clin Nutr"},{"key":"2026032100533759900_bib44","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.clnu.2010.04.007","article-title":"Abdominal fat mass contributes to the systemic inflammation in chronic obstructive pulmonary disease","volume":"29","author":"Rutten","year":"2010","journal-title":"Clin Nutr"},{"key":"2026032100533759900_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","article-title":"Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty","volume":"51","author":"Ershler","year":"2000","journal-title":"Annu Rev Med"},{"key":"2026032100533759900_bib46","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1378\/chest.09-1710","article-title":"Chronic renal failure: a neglected comorbidity of COPD","volume":"137","author":"Incalzi","year":"2010","journal-title":"Chest"},{"key":"2026032100533759900_bib47","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1378\/chest.11-2413","article-title":"Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the Epoc en Servicios de Medicina Interna (ESMI) study","volume":"142","author":"Almagro","year":"2012","journal-title":"Chest"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/187\/7\/728\/67266928\/ajrccm_187_7_728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/187\/7\/728\/67266928\/ajrccm_187_7_728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:54:11Z","timestamp":1774068851000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/187\/7\/728\/8510078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,4,1]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201209-1665oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,4]]},"published":{"date-parts":[[2013,4,1]]}}}